We provide 1 form of Enasidenib
Enasidenib
1446502-11-9
|
473.14
|
3.906
Enasidenib is an isocitrate dehydrogenase-2 inhibitor used to treat relapsed or refractory acute myeloid leukemia with an isocitrate dehydrogenase-2 mutation.
AG-221 | enasidenib
Enasidenib is an isocitrate dehydrogenase-2 inhibitor used to treat relapsed or refractory acute myeloid leukemia with an isocitrate dehydrogenase-2 mutation.
AG-221 | enasidenib
$51/5 mg
(EBC)
1
We provide 0 compound for Enasidenib